Literature DB >> 2136118

Longitudinal substance use and adult adjustment.

J G Tubman1, J R Vicary, A von Eye, J V Lerner.   

Abstract

Relationships among long-term use patterns of tobacco, alcohol, marijuana, and other substances from late childhood to young adulthood and adjustment in young adulthood were examined. The sample consisted of 133 participants from the New York Longitudinal Study. Cluster analysis revealed four groups of individuals for each of the substance categories, as well as for use of multiple substances, over the five points of measurement. Cluster membership was related to adjustment differences in young adulthood. Results from a series of ANOVAs indicated that individuals consistently using the highest amounts of alcohol and other drugs exhibited the highest levels of psychiatric symptoms. Follow-up analyses indicated that negative emotional-behavioral states in middle childhood precede problematic patterns of substance use. Implications for intervention in childhood are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2136118     DOI: 10.1016/s0899-3289(10)80004-5

Source DB:  PubMed          Journal:  J Subst Abuse        ISSN: 0899-3289


  4 in total

1.  Similarities and differences of longitudinal phenotypes across alternate indices of alcohol involvement: a methodologic comparison of trajectory approaches.

Authors:  Kristina M Jackson; Kenneth J Sher
Journal:  Psychol Addict Behav       Date:  2005-12

2.  A model-based cluster analysis approach to adolescent problem behaviors and young adult outcomes.

Authors:  Eun Young Mun; Michael Windle; Lisa M Schainker
Journal:  Dev Psychopathol       Date:  2008

3.  Prevalence of substance use among college students in Eldoret, western Kenya.

Authors:  Lukoye Atwoli; Prisca A Mungla; Moses N Ndung'u; Kiende C Kinoti; Evans M Ogot
Journal:  BMC Psychiatry       Date:  2011-02-28       Impact factor: 3.630

4.  Substance use among inmates at the Eldoret prison in Western Kenya.

Authors:  Daniel W C Kinyanjui; Lukoye Atwoli
Journal:  BMC Psychiatry       Date:  2013-02-13       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.